期刊文献+

允许性高碳酸血症通气治疗新生儿急性呼吸衰竭疗效观察 被引量:27

Clinical application of permissive hypercapnia ventilation to neonatal acute respiratory failure
下载PDF
导出
摘要 目的 探讨允许性高碳酸血症通气(PHV)治疗新生儿急性呼吸衰竭的疗效。方法 14例呼吸衰竭新生儿采用辅助/控制或容量控制模式,并采用PHV通气策略(PaCO_2<10.6 kPa,PH>7.15)。其参数设定为潮气量(VT)6~8 ml/kg,呼吸频率(RR)20~30次/min,气道峰压(PIP)<3.43 kPa,吸入氧浓度(FiO_2)由0.8逐渐降至0.3,吸/呼比(I:E)为1:1.5~2.0,同时监测PHV前后动脉血气(ABG)、心率(HR)、血压(BP)。结果通气前PaO_2为5.05±0.65 kPa,血pH值7.16±0.08,PaCO_2为9.55±1.22 kPa。在采用PHV模式2~6、24、72 h后,血pH值和PaO_2均明显上升(P<0.01),而PaCO_2则在72 h内保持一定范围高水平后渐下降。14例均存活,无发生气压伤及心血管系统并发症。结论 采用PHV配合充分氧疗,逐步降低PaCO_2,提高pH至正常范围,有助于防止气压伤等并发症,是抢救新生儿急性呼吸衰竭较安全、有效的机械通气方法。 Objective To investigate the effect of permissive hypercapnia ventilation(PHV) in dealing with neonatal acute respiratory failure (ARF). Methods Fourteen cases with ARF were treated by PHV,and ventilation mode was set as assistant/control or volume-control with PHV (PaCO>2<10.6 kPa,pH>7.15). Ventilation parameters were tidal volume(VT) 6~8 ml/kg,respiratory rate(RR) 20-30 breaths/min.peak inspiratory pressure(PIP)<3.43 kPa.FiO2 0.8 reduced to 0.3,1:E 1:1.5-2.0. And arterial blood gas(ABG) .heart rate(HR),blood pressure(BP) were determined before and after PHV. Results Before treatment, the mean value of PaO2 was 5.05 + 0.65 kPa,pH was 7.16 + 0.08,and PaCO2. was 9.55 + 1.22 kPa. After 2-6 hours, 24 hours.and 72 hours of PHV,and PaO2 were all raised remarkably (P<0.01). However,PaCO2 was lowered step by step above higher level in 72 hours. All cases survived without barotrauma or cardiovascular complications. Conclusions With sufficient oxygen support, PHV may gradually decrease PaCO2 and raise pH to normal levels. It is proved to be an effective mechanical ventilation therapy for neonatal ARF and barotrauma can be prevented.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2003年第8期622-623,共2页 Journal of Applied Clinical Pediatrics
关键词 高碳酸血症 机械通气 呼吸衰竭 急性 气压伤 婴儿 新生 hypercapnia mechanical ventilation acute respiratory failure barotrauma neonate.
  • 相关文献

参考文献6

二级参考文献21

  • 1[1]Northway WH , Rosan RC, Portor DY. Pulmonary disease following respirator therapy of hyaline- membrane disease [J]. New Engl J Med, 1967;276:357~368
  • 2[2]Mecolley SA . Bronchopulmonary dysplasia: impact of surfactant replacement therapy [J]. Pediatr Clin North Am, 1998; 45: 573~585
  • 3[3]Cherukupalli K, Larson JE, Rotschild A, et al. Biochemical, clinical, and morphologic studies on lungs of infants with bronchopulmonary dysplasia[J]. Pediatr Pulmonol, 1996;22:215~229
  • 4[4]Abman SH, Groothius JR. Pathophysiology and treatment of bronchopulmonary dysplasia, current issues[J]. Pediatr Clin North Am,1994;41:277~315
  • 5[5]Warner BB, Stuart LA, Papes RA, et al. Functional and pathological effects of prolonged hyperoxia in neonatal mice[J]. Am J Physiol,1998; 275: L110~117
  • 6[6]Wang EE, Ohlsson A, Kellner JD. Association of ureaplasma urealyticum colonization with chronic lung disease of prematurity: results of a metaanalysis[J]. J Pediatr, 1995; 127: 640~ 644
  • 7[7]Niu JO, Munshi UK, Siddiq MM, et al. Early increase in endothelin-1 in tracheal aspirates of preterm infants: correlation with bronchopulmonary dysplasia[J]. J Pediatr, 1998; 132:965~970
  • 8[8]Oppenheim C, Mamou MT, Sayegh N, et al. Bronchopulmonary dysplasia: value of CT inidentifying pulmonary sequelae[J]. Am J Roentgenol, 1994; 163:169~ 172
  • 9[9]Schindler MB. Strategies to prevent chronic neonatal lung disease [J]. J Paediatr Child Health, 1996;32:477~479
  • 10[10]Bancalari E. Corticosteroids and neonatal chronic lung disease[J].Eur J Pediatr, 1998;157(Suppl 1):S31~37

共引文献32

同被引文献135

引证文献27

二级引证文献126

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部